NCT03691636 is a NA clinical trial of Eyelash prostheses in Dry Eye, sponsored by D.E.L., LLC.

Who is sponsoring NCT03691636?

NCT03691636 is sponsored by D.E.L., LLC.

What drugs are being tested in NCT03691636?

Interventions in NCT03691636: Eyelash prostheses, 5.0% Lifitegrast Ophthalmic Solution.

Is NCT03691636 still recruiting?

NCT03691636 is currently status unknown. Last updated 2 October 2018.

Last reviewed 2018-10-02 · How we verify

NCT03691636

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Eyelash Prostheses Compared to 5.0% Lifitegrast BID for Dry Eye Disease.

Status unknown NA Last updated 2 October 2018

What this trial tests

NA trial testing Eyelash prostheses in Dry Eye in 40 participants. Status unknown.

Timeline

2 October 2018

Primary endpoint
2 April 2019

1 May 2019

Quick facts

Lead sponsor	D.E.L., LLC
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	40
Start date	2 October 2018
Primary completion	2 April 2019
Estimated completion	1 May 2019
Sites	1 location across United States

Drugs / interventions tested

Eyelash prostheses
5.0% Lifitegrast Ophthalmic Solution

Conditions studied

Dry Eye — all drugs for Dry Eye →

Sponsor

D.E.L., LLC

Who can join

50 and older, any sex, with Dry Eye. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a single-center, randomized, controlled trial to evaluate the safety and efficacy of eyelash prostheses versus 5.0% Lifitegrast BID, in 40 patients (20 randomized to each of two arms of the study) evaluated at 3 weeks and 5 weeks, respectively, after initiation of treatment.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Dry Eye

Currently open trials in the same condition.

NCT07366944 — PCOS and Problem of Eye Dryness: Is There a Benefit From Lifetyle Changes · NA · recruiting
NCT07329712 — Comparing Tear Proteomics Profile in Dry Eye Disease pre-and Post-treatment With Low Level Light Therapy · recruiting
NCT07266948 — Impact of TRYPTYR on a Patient's Quality of Life and Ability to Perform Work · Phase 4 · recruiting
NCT07298811 — Preliminary Clinical Study of the Effectiveness and Safety of Ocular Surface Microbiota Transplantation in the Treatment · Phase 1, PHASE2 · recruiting
NCT07135193 — Evaluation of the Protective Effects of Cordyceps Cicadae on Visual Function and Anti-Fatigue Performance in Esports Ath · NA · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03691636 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by D.E.L., LLC
Last refreshed: 2 October 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03691636.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing